AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS

RecruitingNAAges 18 Years - 85 YearsAllUniversity Hospital, Montpellier
💬

In plain words

What the trial is, and whether it could suit you

Disorders of glycemic regulation are common in patients hospitalized for acute coronary syndrome (ACS). Abnormal glycaemia is observed in 50% of cases, in 30-40% diabetes, and in 25-35% fasting hyperglycaemia or glucose intolerance. Hyperglycemia is a major prognostic factor in ACS, with admission hyperglycemia having independent prognostic value for both short- and long-term major cardiovascular events (MACE), regardless of the presence of diabetes. Metabolically, several situations can be distinguished: * Hyperglycaemia occurs in known non-diabetic ACS subjects. It can be indicative of (i) Type 2 Diabetes or (ii) stress hyperglycaemia (diagnostic threshold for blood sugar varies according to learned societies, with HbA1c \< 6.5%). * Hyperglycaemia occurs in known diabetic ACS subjects Most studies use admission blood sugar as a predictor. However, it has recently been shown that gly

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with ACS managed in a cardiac intensive care unit (ICU). The diagnosis of ACS will be made in the presence of chest pain with ST-segment elevation on the ECG for STEMI or ST-segment change and/or a positive troponin cycle (values in accordance with the center's protocol) for NSTEMI. Exclusion Criteria: * Subjects in cardiogenic or septic shock * Subjects with ACS initially managed in a non-investigating center * Failure to obtain free, informed, written consent signed by the participant and investigator upon admission to the ICU * Person participating in another research study with an ongoing exclusion period * Subjects participating in a study that may have an impact on post ACS prognosis * Person deprived of his or her rights, person under guardianship or curatorship * Person deprived of liberty (by judicial or administrative decision) * Persons whose physical and/or psychological health is severely impaired, which, in the opinion of the investigator, may affect the participant's compliance to the study * Pregnant or breastfeeding women * Person who is not affiliated to a social security system or who is a beneficiary of such a system.
💊

What it tests

  • Freestyle Libre Pro iQ
📍

Where

9 sites
Hospital of Béziers
Béziers, France
University Hospital of Bordeaux
Bordeaux, France
University Hospital of Montpellier
Montpellier, France
University Hospital of Nîmes
Nîmes, France
AP-HP Lariboisière Hospital
Paris, France
APHP - Hôpital Européen Georges Pompidou
Paris, France
Hospital of Pau
Pau, France
University Hospital of Toulouse
Toulouse, France

…and 1 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy